Effect of Anti-PEG Antibody on Immune Response of mRNA-Loaded Lipid Nanoparticles
Molecular Pharmaceutics · 04.11.2024 · 21 (11) · 5672-5680
DOI: 10.1021/acs.molpharmaceut.4c00628 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 26.09.2024. Verfasst von Daiki Omata und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Drug and Gene Delivery Research, Faculty of Pharmaceutical Sciences, Teikyo University, Tokyo 173-8605, Japan. Hauptthemen laut MEDLINE: Nanoparticles, Polyethylene Glycols, Ovalbumin, RNA, Messenger. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Takeda Science Foundation, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Lipid nanoparticle-encapsulated mRNA (mRNA-LNP) vaccines have been approved for use to combat coronavirus disease 2019 (COVID-19). The mRNA-LNPs contain PEG-conjugated lipids. Clinical studies have reported that mRNA-LNPs induce the production of anti-PEG antibodies, but the anti-PEG antibodies do not affect the production of neutralizing antibodies. However, the detailed influence of anti-PEG antibodies on mRNA-LNP vaccines remains unclear. Therefore, in this study, we prepared ovalbumin (OVA) as a model antigen-encoding mRNA-loaded LNP (mRNA-OVA-LNP), and we determined whether anti-PEG antibodies could affect the antigen-specific immune response of mRNA-OVA-LNP vaccination in mice pretreated with PEG-modified liposomes to induce the production of anti-PEG antibodies. After intramuscular (i.m.) injection of the mRNA-LNP, the anti-PEG antibodies did not change the expression of protein or induction of cytokine and cellular immune response but did slightly increase the induction of antigen-specific antibodies. Furthermore, repeated mRNA-LNP i.m. injection induced the production of anti-PEG IgM and anti-PEG IgG. Our results suggest that mRNA-LNP induces the production of anti-PEG antibodies, but the priming of the antigen-specific immune response of mRNA-LNP vaccination is not notably affected by anti-PEG antibodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Drug and Gene Delivery Research, Faculty of Pharmaceutical Sciences, Teikyo University, Tokyo 173-8605, Japan.
- Laboratory of Nano-design for Innovative Drug Development, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan.
- Vaccine Creation Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
- Laboratory of DDS Design and Drug Disposition, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai City, Miyagi 980-8578, Japan.
- Center for Advanced Modalities and DDS, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
- Vaccine Creation Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
ORCID-Profile: Daiki Omata, Hidetaka Akita, Yasuo Yoshioka, Ryo Suzuki
Förderung
- Takeda Science Foundation
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Omata, D., Kawahara, E., Munakata, L., Tanaka, H., Akita, H., Yoshioka, Y., & Suzuki, R. (2024). Effect of Anti-PEG Antibody on Immune Response of mRNA-Loaded Lipid Nanoparticles. Molecular Pharmaceutics, 21(11), 5672-5680. https://doi.org/10.1021/acs.molpharmaceut.4c00628
Vancouver
Omata D, Kawahara E, Munakata L, Tanaka H, Akita H, Yoshioka Y, et al. Effect of Anti-PEG Antibody on Immune Response of mRNA-Loaded Lipid Nanoparticles. Molecular Pharmaceutics. 2024;21(11):5672-5680. doi:10.1021/acs.molpharmaceut.4c00628
BibTeX
@article{Omata2024,
author = {Omata, Daiki and Kawahara, Eigo and Munakata, Lisa and Tanaka, Hiroki and Akita, Hidetaka and Yoshioka, Yasuo and Suzuki, Ryo},
title = {Effect of Anti-PEG Antibody on Immune Response of mRNA-Loaded Lipid Nanoparticles},
journal = {Molecular Pharmaceutics},
year = {2024},
volume = {21},
number = {11},
pages = {5672--5680},
doi = {10.1021/acs.molpharmaceut.4c00628}
}
EUVIMED